ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_8_84 # 66141 # 66281 # -1 # ID=8_84;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.489	scaffold_8_84 	66141	66281	-	Strict	500	20.7866	APH(3')-Vb	100.0	3002650	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGTGGCCTGAAGACGAGAGATTGACAAAGAGAAAGATCGAAACCATCTTAGGCATTGCGCAAAGGCATAACCAAAAGGTCGTCATCCTAGGAGCGTTTGGGTGCGGCGTAGGTGCCTCTTCAGATTCCAGCTGCCTGTAA	MWPEDERLTKRKIETILGIAQRHNQKVVILGAFGCGVGASSDSSCL	MESTLRRTYPHHTWHLVNEGDSGAFVYRLTGHGPELYAKIAPRTPENSAFHLDGEADRLDWLARHGISVPRVVERGADDTTAWLVTEAVPGAAASEEWPEDERAAVVDAIAEMARTLHELPVSECPFDRRLDVTGEARHNVREGLVDLDDLQEEPAGWTGDQLLAELDLTRPEKEDLVVCHGDLCPNNVLLDPETHRITGLIDVGRLRLATCHADLALAARELAIDEDPWFGPAYAERFLERYGAHHVDQEKMAFYQLLDEFF	17.49	gnl|BL_ORD_ID|1456|hsp_num:0	1548	True	loose hit with at least 95 percent identity pushed strict
scaffold_32_29 # 21287 # 21379 # -1 # ID=32_29;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.634	scaffold_32_29 	21287	21379	-	Strict	400	19.631	vanRA	100.0	3002919	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGGCTGAAGCGGTGGAAATATGGGGCGACGAGCGCGCGGAGGCGTTCTTTGACGTGGAAGGGGAACTCGCCCGTGACTGGGACAGCGCGTAG	MAEAVEIWGDERAEAFFDVEGELARDWDSA	MSDKILIVDDEHEIADLVELYLKNENYTVFKYYTAKEALECIDKSEIDLAILDIMLPGTSGLTICQKIRDKHTYPIIMLTGKDTEVDKITGLTIGADDYITKPFRPLELIARVKAQLRRYKKFSGVKEQNENVIVHSGLVINVNTHECYLNEKQLSLTPTEFSILRILCENKGNVVSSELLFHEIWGDEYFSKSNNTITVHIRHLREKMNDTIDNPKYIKTVWGVGYKIEK	12.99	gnl|BL_ORD_ID|680|hsp_num:0	722	True	loose hit with at least 95 percent identity pushed strict
scaffold_34_102 # 88459 # 88653 # -1 # ID=34_102;partial=00;start_type=ATG;rbs_motif=4Base/6BMM;rbs_spacer=13-15bp;gc_cont=0.518	scaffold_34_102 	88459	88653	-	Strict	500	21.1718	OXA-42	100.0	3001769	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGGAAGCAGGGTCTGCAGAGGTCAGCTGTTGTTCTTGTTGTGGTTGTAGTACTGACCCAACACGCTGGTTAGACCCGCGATGGAGTGATGGAAGTGGAGCTCGAACGGTTGGAGACTCACCTGAAAGCGTGGACGCTGAAGAAGAAACCGAAGAAGAACTGCATCAAGGAGCCATCGCTCACAGAAAGTGA	MTEAGSAEVSCCSCCGCSTDPTRWLDPRWSDGSGARTVGDSPESVDAEEETEEELHQGAIAHRK	MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAISLMGYDAGFLRNEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQRFAQYAKAFGYGNADVSGDPGQNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAVDMTERIVESTTLADGTVVHGKTGVSYPLLADGTRDWARGSGWFVGWIVRGNQTLVFARLTQDERKQPVSAGIRTREAFLRDLPRLLAAR	23.79	gnl|BL_ORD_ID|1628|hsp_num:0	1728	True	loose hit with at least 95 percent identity pushed strict
scaffold_59_149 # 119926 # 120201 # 1 # ID=59_149;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.446	scaffold_59_149 	119926	120201	+	Strict	700	21.557	Klebsiella pneumoniae KpnG	100.0	3004588	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; penam; peptide antibiotic; penem	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGTTTGTGCAGAATGCAAAAATTATCCTCACCCTCTCGAACTTGAAATCTTGCCATTAAATAATCTAATGATTTCCTCTTCATTTCAGACTCCTCAGCAACCTGGATTTTCCGCATTGCGCGGCGAGGTCGAGATAGTAGTTCATTGCGACGATGAATTGTTCCTAGAAGTGATGGAGGATCAGAAATCTTCCCAAATATCGCTGCGGGACAGACGTGGTTCTCTGCCTTTCTTCTTCTGCGGATTCTCGATGCTACGATTTACCGTCCTGTAG	MVCAECKNYPHPLELEILPLNNLMISSSFQTPQQPGFSALRGEVEIVVHCDDELFLEVMEDQKSSQISLRDRRGSLPFFFCGFSMLRFTVL	MSANAESQTPQQPGSKKGKRKGALLLLTLLFIIIAVAYGIYWFLVLRHYEETDDAYVAGNQVQIMAQVAGSVTKVWADNTDYVQKGDPLVTLDRTDAQQAFEKAKTQLAASVRQTRQQMINSKQLQANIDVKKTALSQAQADLNRRIPLGAANLIGREELQHARDTVASAQAELDVAIQQYNANQAIVLGTRLEQQPAVLQAATEVRNAWLALQRTQIVSPISGYVSRRSVQPGAQIGTTTPLMAVVPATNLWIDANFKETQLAHMRIGQPATVISDIYGDDVKYTGKVVGLDMGTGSAFSLLPAQNATGNWIKVVQRLPVRIELDEKQLAEHPLRIGLSTLVEVNTTDRDGEMLASQVRSSPVYESNAREIALDPVNKLIDEIIQANAG	23.33	gnl|BL_ORD_ID|2789|hsp_num:0	3298	True	loose hit with at least 95 percent identity pushed strict
scaffold_72_90 # 66298 # 66432 # -1 # ID=72_90;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.489	scaffold_72_90 	66298	66432	-	Strict	2000	20.0162	Staphylococcus aureus mupA conferring resistance to mupirocin	100.0	3000521	protein homolog model	n/a	n/a	mupirocin	antibiotic target alteration	antibiotic-resistant isoleucyl-tRNA synthetase (ileS)	ATGTCTTTGAGGTGTGGGAATCCATTGTCAGGACTGATTCCAAGACCAGTTATGCCGTTTGTTGAACTGGATTTGGAGTGCGTGATGAAGGAGTGCAGAAGTCGTATGCGTTCAGCCGTCGTGACGGGAGATTGA	MSLRCGNPLSGLIPRPVMPFVELDLECVMKECRSRMRSAVVTGD	MTKKYLNTQNEISAFWNTQKIFKKSIDNRKGQESFVFYDGPPTANGLPHAGHVLGRVIKDLVARLKTMQGFYVERKAGWDTHGLPVELEVEKKIGIKGKQDIEKYGIENFINECKKSVFNYEKEWRDFSKDLGYWVDMDSPYITLENNYIESVWNILSTFHKKGLLYKGHKVTPYCTHDQTALSSHEVAQGYKNVKDLSAVVKFQLTNSKDTYFLSWTTTPWTLPANVALAINKDLNYSKIRVENEYYILATDLINSIITEKYEIIDTFSGSNLINLKYIPPFESDGLVNAYYVVDGEFVTNSEGTGIVHIAPAHGEDDYQLVLERDLDFLNVITREGVYNDRFPELVGNKAKNSDIEIIKLLSKKQLLYKKQKYEHNYPHCWRCGNPLIYYAMEGWFIKTTNFKNEIINNNNNIEWFPSHIKEGRMGNFLENMVDWNIGRNRYWGTPLNVWICNDCNHEYAPSSIKDLQNNSINKIDEDIELHRPYVDNITLSCPKCNGKMSRVEEVIDVWFDSGSMPFAQHHYPFDNQKIFNQHFPADFIAEGVDQTRGWFYSLLVISTILKGKSSYKRALSLGHILDSNGKKMSKSKGNVINPTELINKYGADSLRWALISDSAPWNNKRFSENIVAQTKSKFIDTLDNIYKFYNMYNKIDHYNPNNEITKSRNTLDNWALSRLNTLIKESNIYVNNYDFTSAARLINEYTNTISNWYIGDSRGRFWEQGISNDKKDAYNTLYEILTTLSRLVAPFVPFISEKIHYNLTGKSVHLQDYPQYKESFINQALEDEMHTVIKIVELSRQARKNADLKIKQPLSKMVIKPNSQLNLSFLPNYYSIIKDELNIKNIELTDNINDYITYELKLNFSSVGPKLGNKTKNIQTLIDSLSEYDKKSLIESNNFKSLSSDAELTKDDFIIKTLPKDSYQLSEDNDCVILLDKNLSPELIREGHARELIRLIQQLRKKKNLPINQRIDIYIGVTGELLESIKTNKNMFKENFVIKNIHLNVIDEYENTIHFNNKEIKISLLY	4.30	gnl|BL_ORD_ID|2125|hsp_num:0	2270	True	loose hit with at least 95 percent identity pushed strict
scaffold_75_16 # 12722 # 12859 # 1 # ID=75_16;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.652	scaffold_75_16 	12722	12859	+	Strict	1900	20.7866	mexN	100.0	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCGAGGGCGGAATGGGGGAGGGCGAGAGTGGCGGCGGTGTCGACATGGCGGGTGAGCGGGGTGGATTGGAGGGTATCAGCGGTTGGTGTGACGCCTCAGAGGGCTGCTGTGTCTCCTGTCGCAAGGTGAGTTGA	MGEGGMGEGESGGGVDMAGERGGLEGISGWCDASEGCCVSCRKVS	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	4.34	gnl|BL_ORD_ID|2066|hsp_num:0	2217	True	loose hit with at least 95 percent identity pushed strict
scaffold_76_26 # 17622 # 17909 # -1 # ID=76_26;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.538	scaffold_76_26 	17622	17909	-	Strict	550	22.3274	OXA-306	100.0	3001761	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGATGGGTGGGGGATGGATGTTAATGCTAAGACAGTGAGATATGATACCGATGACATTGCGATCTGCTTCGTCCTCTTGCGCTCGCTGAACGGTTTCCTTCCCGTCTCGGTTCAACTGTCTCCATCCCGTCTAGCGTTCATCTCTCATCCTCCGGAAACAAGCCTCTATTTTTCGAGAACACGACAGCTGAAGGACGGCACAGAGAGGGCTCAAATCTCAAGGGGGTGCATGGTGACAAAGGCGGCGGTGAGGGTCCGGGAGGAGGTGTGGGAGCAAGATGTCTGA	MDGWGMDVNAKTVRYDTDDIAICFVLLRSLNGFLPVSVQLSPSRLAFISHPPETSLYFSRTRQLKDGTERAQISRGCMVTKAAVRVREEVWEQDV	MSKRLKTLALSASFTFALPLVACQSFGDQTQHIMAQKSEQQNIATLFQQAQTSGVLVIYDGKKIQKYGNDTSRAEQRYIPASTFKMLNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEEVRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVNPQVGWWTGWIEQANGKVTAFSLNMEMNRPEHADARKAIVYQALQQLDLLAN	34.17	gnl|BL_ORD_ID|2612|hsp_num:0	3468	True	loose hit with at least 95 percent identity pushed strict
scaffold_87_85 # 55745 # 56092 # -1 # ID=87_85;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.526	scaffold_87_85 	55745	56092	-	Strict	150	21.557	dfrB2	100.0	3003021	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	GTGAAGACGCTCGAGTCCCTCTCTGATCGACTGCAGTCGCAGAAGACGCCCGAAAAGATGAAGCAAGCCGTAATCAAGGGCATTCCCCGTACGGCAGTGCTGAAACCTGATCACACGGCCAGTCGGCTGCAGGGGCAGACCTTTGGTCTTGGAGACCGAGTTATAATGGTTTCTGACACTGGGAATGTCCCACTTTCAGCGAAGGGTGTGGTGATTGGCGTGCAATCGTCGTTGATTGATGTAGTATTTGATGTACCCTTTATGGCAGGAAGTAATCTCGGCGGGCGGTTCGTTCTCTTCCCTTCCACAGTCTCCTATCGATGCAGAATGCTGAATGGTTGTCGATAG	MKTLESLSDRLQSQKTPEKMKQAVIKGIPRTAVLKPDHTASRLQGQTFGLGDRVIMVSDTGNVPLSAKGVVIGVQSSLIDVVFDVPFMAGSNLGGRFVLFPSTVSYRCRMLNGCR	MGQSSDEANAPVAGQFALPLSATFGLGDRVRKKSGAAWQGQVVGWYCTKLTPEGYAVESESHPGSVQIYPVAALERVA	147.44	gnl|BL_ORD_ID|1863|hsp_num:0	1971	True	loose hit with at least 95 percent identity pushed strict
scaffold_98_23 # 27304 # 27459 # -1 # ID=98_23;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.551	scaffold_98_23 	27304	27459	-	Strict	900	22.3274	PmpM	100.0	3004077	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic; benzalkonium chloride	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	GTGCTGGAGAGAAGTACCGTCGGAGAGGATGCGGGCAGTCATGGCGAGTGGAAGAAGGAGGAGGAGGATGCCCTGGAGGAGACCATAAGGCAACATGAGAGGTTGCAGTGTGGAACGGAATTGTTGATGACAGATGATGTGGATCGGAGAGATTGA	MLERSTVGEDAGSHGEWKKEEEDALEETIRQHERLQCGTELLMTDDVDRRD	MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR	10.69	gnl|BL_ORD_ID|2443|hsp_num:0	2734	True	loose hit with at least 95 percent identity pushed strict
scaffold_106_53 # 40477 # 40626 # 1 # ID=106_53;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.533	scaffold_106_53 	40477	40626	+	Strict	2200	20.4014	rpoB2	100.0	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGAGGAAGCCTTCGGTATCTATGAAAGATATGGCGTTTGCGTTCGGTGAGAAGGCTAGAGAGGTCGCGAGAGAGGTGGAGACTGACGTCGCCGAGATTGGGGTCTTAGTGATGGGAGAATGCGAAACGCTGTCCCAAATGACGACGTAG	MRKPSVSMKDMAFAFGEKAREVAREVETDVAEIGVLVMGECETLSQMTT	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	4.22	gnl|BL_ORD_ID|2485|hsp_num:0	2831	True	loose hit with at least 95 percent identity pushed strict
scaffold_112_88 # 68284 # 68427 # -1 # ID=112_88;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.514	scaffold_112_88 	68284	68427	-	Strict	450	20.4014	rmtB	100.0	3000860	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGACTTCAATACTACAGCCGGCGATCATGGCAAGTACTGGTGAGCTGATCCTCTCGCCTCACGACGGAGTAGAGCACTCATTCGTAATTGTGCAGGACGACTGCAAGCTTCTACCCCTACTGGAGCGGTATTTGGCCTCGTGA	MTSILQPAIMASTGELILSPHDGVEHSFVIVQDDCKLLPLLERYLAS	MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTPESLKAAAAALSAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALYERGIASVWGCDIHQGLGDVITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLLEREQAGSAMALLQSLNTPRMAVSFPTRSLGGRGKGMEANYAAWFEGGLPAEFEIEDKKTIGTELIYLIKKNG	18.73	gnl|BL_ORD_ID|850|hsp_num:0	904	True	loose hit with at least 95 percent identity pushed strict
scaffold_125_18 # 15150 # 15308 # 1 # ID=125_18;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.503	scaffold_125_18 	15150	15308	+	Strict	400	21.1718	Erm(39)	100.0	3000602	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGAACACACCTCATGTCCATCCTCGCGCCACCGAGTTCAATCTCGCCATCAAGTGCGTCTTCTCCCAACGCTGCTACAATAATATTGACCTTGCGTGCGTTTCTACAGTGGCACGCTCCGCTCCGGATTTGTGCAAGAGAATGGAGCAAAGTTCATAA	MNTPHVHPRATEFNLAIKCVFSQRCYNNIDLACVSTVARSAPDLCKRMEQSS	MSSVHHGRHENGQNFLRDRRVVGDIVRMVSHTAGPIVEIGAGDGALTLPLQRLGRPLTAIEIDLHRARRLADRTTAEVIATDFLRYRLPRTPHVVVGNLPFHLTTAILRRLLHENGWTDAILLVQWEVARRRAGVGGATMMTAQWWPWFEFGLARKVSADAFRPRPSVDAGLLTIQRRAEPLLPWADRRAYQALVHRVFTGRGRGLAQILRPHVHPRWLSANGIHPSALPRALTARQWVALFDAAG	21.14	gnl|BL_ORD_ID|1604|hsp_num:0	1701	True	loose hit with at least 95 percent identity pushed strict
scaffold_149_30 # 25345 # 25509 # -1 # ID=149_30;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.485	scaffold_149_30 	25345	25509	-	Strict	700	20.4014	Acinetobacter baumannii AbaF	100.0	3004573	protein homolog model	n/a	n/a	fosfomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCGGAGCCGAAAAATCTGGCTCCGGAGCGAATGTTGCGCGTCGTGATTGTGATGAGATTTTCAGGGAAGAGGGTGGGTGGAGGGATTGGGGATGGAGATATGAAGGGAAGTTTCTCTCGCCTATTCAAAGTGATGGTATTGTGAGAAGTGCTACATACTAG	MSGAEKSGSGANVARRDCDEIFREEGGWRDWGWRYEGKFLSPIQSDGIVRSATY	MTTTLKKVVAASMVGSVAEWYEFFLYGTASALVFGELFFQQTGNAIDGILAAFALYAVGFLARPLGGLVFGHYGDKIGRKKLLQISLIIVGITTFLMGCIPTFHQIGYWAPTLLVILRLIQGFAFGGEWGGAVILVSEHSPDDRRGYWASWPQTGVPLGNLVATLVLLLLSKNLSPEQFLDWGWRCAFWFSAVVVLIGLWIRKNVDDAEVFKEAQAKQQLLEKQQLGIIEVLKYHKKSVIAGIGARFAENILYYMVVTFSISYLKLVVHKDTSQILLLMFGAHLIHFFIIPFMGHLSDIFGRKPIYLIGAVLTAFWGFVGFPLMDTGNDWLIMLAIVLGLFIESMTYSPYSALMTELFPTHIRYTALSFCYQVAPIMAGSLAPLIALTLLKEFNSSIPISLYLVAASLISIVSILLVKETKGRSLAFKD	12.59	gnl|BL_ORD_ID|2772|hsp_num:0	3277	True	loose hit with at least 95 percent identity pushed strict
scaffold_164_10 # 7469 # 7603 # -1 # ID=164_10;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.548	scaffold_164_10 	7469	7603	-	Strict	900	20.4014	norB	100.0	3000421	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTCTTCGGCCGAATGCCGATGTGAGTATCGCCGATATCCGACACGGCGTTAAGCGGATACTTCTTTCCTGTGTCCACTTCGCAGCTAGCAAGGAGAGTGTTATCGAGGATGGGGCTGACCGGCAACGTTAG	MTLRPNADVSIADIRHGVKRILLSCVHFAASKESVIEDGADRQR	MTSTAYKGTNKLIVGIVFGVITFWLFAQSMVNIVPAVQSDLGISSDLLSIAISLTALFSGIFIVVAGGMADKFGRVKLTYIGLILSIIGSLLLVVTQGSTLLIIGRIIQGLSAACIMPATLALMKTYFDGADRQRALSYWSIGSWGGSGICSFAGGAIATYMGWRWIFIISIVFALLGMLLIKGTPESKVVQNTKAKFDSFGLVLFVIAMVCLNLIITRGATFGWTSPITITMLVVFLVSAGLFFRVELRQANGFIDFSLFKNKAYTGATLSNFLLNAAAGTLVVANTYVQIGRGFTAFQSGLLSIGYLVCVLGMIRIGEKILQRVGARKPMILGSGITAVGIALMALTFIPGTLYTVLVFIGFALFGIGLGMYATPSTDTAISNAPEDKVGVASGIYKMASSLGGSFGVAISATIYGVIALSGNIDLAAMVGLLTNVGFCVVSLISVAITTPSAKKALELKAAKE	9.44	gnl|BL_ORD_ID|1102|hsp_num:0	1167	True	loose hit with at least 95 percent identity pushed strict
scaffold_209_9 # 9544 # 9762 # 1 # ID=209_9;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.639	scaffold_209_9 	9544	9762	+	Strict	550	21.557	CAU-1	100.0	3000855	protein homolog model	n/a	n/a	carbapenem; penam	antibiotic inactivation	CAU beta-lactamase	GTGGAGCATGCGCGAGAAGGTGTAGGCGGAGGTGAGGAGCTGGGAGAGGGAGGGGTCGAGTTGGGAGGGGTGCGGGGAGATGATGGGGAAGGTGCTGGGGAGGTGTTCGGTCAGGATGGTGAGTGCGAGAGAGGGATCGATCGAGTCCACGGCGGCGGAGAAGGTCTGGCGTCGCCAGACGGCGGCTACGAGAGGTTCCCCTGTTCGTTGTCAGTATGA	MEHAREGVGGGEELGEGGVELGGVRGDDGEGAGEVFGQDGECERGIDRVHGGGEGLASPDGGYERFPCSLSV	MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISRDDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWTTAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQGNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPNR	24.91	gnl|BL_ORD_ID|1041|hsp_num:0	1109	True	loose hit with at least 95 percent identity pushed strict
scaffold_216_13 # 8060 # 8227 # -1 # ID=216_13;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.518	scaffold_216_13 	8060	8227	-	Strict	400	20.4014	IND-5	100.0	3002261	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGGGAGGCCGCGCAGATGATTGGAAGGGAGGTATGTTTAATGGACGAGTCGGAGCGCGCCTGGTGCGGTCTCTTCAGCGAGTTAATTTTCAAGTCAGAGCCAACTTACCATGGATCGCAGCGGAGACTGAAGTCAATGGGCATGTTGTTGGATTAATTGCTGGATGA	MGGRADDWKGGMFNGRVGARLVRSLQRVNFQVRANLPWIAAETEVNGHVVGLIAG	MKKRIQFFMVSMMLAPMFNAQVKDFVIEPPIKNNLHIYKTFGVFGGKEYSANSVYLVTKKGVVLFDVPWEKAQYQSLMDTIKKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSKTNEFLKKDGKATSTEIIKTGKPYRIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSNSATDLGYIKEANVEQWPITIDKLKAKYSKATLIIPGHDDWKGGGHVEHTLELLNKK	23.01	gnl|BL_ORD_ID|1232|hsp_num:0	1306	True	loose hit with at least 95 percent identity pushed strict
scaffold_255_63 # 51762 # 51989 # 1 # ID=255_63;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.500	scaffold_255_63 	51762	51989	+	Strict	500	21.1718	APH(3')-Vc	100.0	3002651	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	ATGTTGCTCGGTGGCGGAGGTTATACGGTGCGCAACGTTGCCAGGGCATGGGCTTACGAAACTGCCACCGCTATCGGGTGTCAGATGGAATTATCAAGGGAGATTCCTTGGAATGATTTCTACGAGTGGTTTGGTCCTGAGTATAAGCTCGAGATCCCAATGACGAATGCCCCGAATGCGAATACGGACAAAGATATGCAGCGAATTGTGTCAGTCCCTTTTCCATGA	MLLGGGGYTVRNVARAWAYETATAIGCQMELSREIPWNDFYEWFGPEYKLEIPMTNAPNANTDKDMQRIVSVPFP	MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLTWLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHELPVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVLCHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRFLERYGAHHVDENKMAFYQLLDEFF	28.41	gnl|BL_ORD_ID|646|hsp_num:0	687	True	loose hit with at least 95 percent identity pushed strict
scaffold_423_40 # 32766 # 32897 # -1 # ID=423_40;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.523	scaffold_423_40 	32766	32897	-	Strict	550	21.1718	ERP-1	100.0	3004782	protein homolog model	n/a	n/a	penam	antibiotic inactivation	ERP beta-lactamase	GTGGATATGCGACAGGTTAACTTGGTCGTCGGGAACGAAGAGGCGATAAAGAAGGCGCTGGAGGGATCTGAGATCGTATTCGTTCGTTTCCCCCTCTGCTCTACTGTGGAAGGAAGTACCAATGAGGGATGA	MDMRQVNLVVGNEEAIKKALEGSEIVFVRFPLCSTVEGSTNEG	MTILLQRRQLLVAGAALALTASLTPLNVFAAGDSLQRQLAALETEVNGRIGLSLIDSASQQAWSYRGDERFPLCSTFKLLLVAAVLKRSESQPALMQQTLHWTPADHLSYMPVTAKHPQGMTVSDLCAAALQYSDNLAANVLLTLLGGPASVTRLARSLGDSVTQLDRNEPTLNTAIPGDPRDTTTPLHMSHSVQQLLVKSGLQTAQQQQLIAWLKGNTTGKNAIAAALPAGWEIGDKTGSGGYGTTNDVAILWPPGKAPLILAIYFTQHAPEAKSRQDVLAKAAAIALKSVI	14.68	gnl|BL_ORD_ID|2796|hsp_num:0	3582	True	loose hit with at least 95 percent identity pushed strict
scaffold_451_31 # 19888 # 19992 # 1 # ID=451_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.495	scaffold_451_31 	19888	19992	+	Strict	700	19.631	pp-flo	100.0	3002812	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGCAAAATGCTGATTCTGCTGGTACACTCACGGAGAACGAGGCCTCAACTCTAGGACGAGTAGGCTGGCGTACCTACAAACGATTCATGGTTTACGGGTGA	MKQNADSAGTLTENEASTLGRVGWRTYKRFMVYG	MTTLHPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMVMLGVGQVIFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDVYANRPEGVVIYGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVKTRRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKSFVARWGIAGCGRVGWRCLFAAVLLGIGELYGSLNSSPSSYRCGLSRSVLSSRCPLPRTALLAEFDDIAGSAVAFYFCVQSLIVSIVGTLAVALLNGDTAWPVIC	9.09	gnl|BL_ORD_ID|1941|hsp_num:0	2058	True	loose hit with at least 95 percent identity pushed strict
scaffold_467_13 # 6978 # 7358 # 1 # ID=467_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.483	scaffold_467_13 	6978	7358	+	Strict	300	23.0978	dfrA29	100.0	3004554	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGATGGTTAGTCCTTTTTATTTCATTGCCAATGATGTGCTGACTCTGATGGCAAGCGAGGCATGTCATTGGCAACATCGAAAACGATTGAGTGATGGGACATCTCTGTCCAACCTTGGCCAACCCGCTGCAGCTGTAGTGCAGGAGTATTGCAAGATCAGGAAATATGTCAGAAGTGAAGGAGATAGAGATGAAGCGATGGGGAGACTTGGAGAATCCCTTCCAATCGGTATGTTGTCTCTCGGAGCCATGATGGAAGGGGAAGGCGTTGACTCTGTGTGCGATTTGGATGCAGAGCTGCTACCTCATGTGCACTCTTCGAGCAGATCAGAAGGTAGGGAAGTTGAGATGTGGGTGCTCAACACTTCCAGTTCTGTATGA	MMVSPFYFIANDVLTLMASEACHWQHRKRLSDGTSLSNLGQPAAAVVQEYCKIRKYVRSEGDRDEAMGRLGESLPIGMLSLGAMMEGEGVDSVCDLDAELLPHVHSSSRSEGREVEMWVLNTSSSV	MAARAKNGVIGCGPNIPWSAKGEQLLFKALTYNQWLLVGRKTFESMGPLPNRKYAVVTRSNWTAANENVVVFPSIDEAMGRLGEITDHVIVAGGGEIYHETIPMASTLHVSTIDVEPEGDVFFPNIPGKFDVVFEQQFTSNINYCYQIWQKG	82.89	gnl|BL_ORD_ID|2764|hsp_num:0	3262	True	loose hit with at least 95 percent identity pushed strict
scaffold_505_15 # 7921 # 8124 # 1 # ID=505_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.632	scaffold_505_15 	7921	8124	+	Strict	1300	21.9422	vanTE	100.0	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGGAAGTGGGGCGCGGGCTCCCGGCGGCGCCCTTCTTCCCTGAGGAATATTGGTGGGCACTCCAGAGAGTGGGTGGGAGCGTTGTACAGGGTTGTGGGATGGTGGAGGTGGCGCTGGGCGAGAGGGGTGATTTTGGCGCGGCAGTGGCTTTTGATTCATGGGGATGGGGGGAGGAGAATGTCTGGGAGGCTGCCTGTGCATAG	MEVGRGLPAAPFFPEEYWWALQRVGGSVVQGCGMVEVALGERGDFGAAVAFDSWGWGEENVWEAACA	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	9.54	gnl|BL_ORD_ID|1234|hsp_num:0	1308	True	loose hit with at least 95 percent identity pushed strict
scaffold_607_17 # 16674 # 16808 # -1 # ID=607_17;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.548	scaffold_607_17 	16674	16808	-	Strict	900	20.4014	norB	100.0	3000421	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACTCTTCGGCCGAATGCCGATGTGAGTGTCCCCGATATCCGACACGGCGTTAACCGGATACTTCTTTACTGTGTCCACTTCGCAGCTAGCAAGGAGAGTGTTATCGAGGATGGGGCTGACCGGCAACGTTAG	MTLRPNADVSVPDIRHGVNRILLYCVHFAASKESVIEDGADRQR	MTSTAYKGTNKLIVGIVFGVITFWLFAQSMVNIVPAVQSDLGISSDLLSIAISLTALFSGIFIVVAGGMADKFGRVKLTYIGLILSIIGSLLLVVTQGSTLLIIGRIIQGLSAACIMPATLALMKTYFDGADRQRALSYWSIGSWGGSGICSFAGGAIATYMGWRWIFIISIVFALLGMLLIKGTPESKVVQNTKAKFDSFGLVLFVIAMVCLNLIITRGATFGWTSPITITMLVVFLVSAGLFFRVELRQANGFIDFSLFKNKAYTGATLSNFLLNAAAGTLVVANTYVQIGRGFTAFQSGLLSIGYLVCVLGMIRIGEKILQRVGARKPMILGSGITAVGIALMALTFIPGTLYTVLVFIGFALFGIGLGMYATPSTDTAISNAPEDKVGVASGIYKMASSLGGSFGVAISATIYGVIALSGNIDLAAMVGLLTNVGFCVVSLISVAITTPSAKKALELKAAKE	9.44	gnl|BL_ORD_ID|1102|hsp_num:0	1167	True	loose hit with at least 95 percent identity pushed strict
scaffold_610_4 # 1884 # 2021 # -1 # ID=610_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.536	scaffold_610_4 	1884	2021	-	Strict	500	20.0162	TEM-137	100.0	3001001	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGGACGGGAGAAGAGGGAGTAGAGGGGGGAGGAGACGGGATACAAATTGCGCCTTTGTTCTTGTTAGGGGAGGTGGAGTGTGGAAGGAGAAGTACCAACCAGTAATGGAAGTTCAGGTGCGGGTGAGGGTGAGCTGA	MDGRRGSRGGRRRDTNCAFVLVRGGGVWKEKYQPVMEVQVRVRVS	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGRRGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	15.73	gnl|BL_ORD_ID|900|hsp_num:0	960	True	loose hit with at least 95 percent identity pushed strict
scaffold_653_11 # 5338 # 5586 # 1 # ID=653_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.494	scaffold_653_11 	5338	5586	+	Strict	500	22.3274	apmA	100.0	3003918	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	amp acetyltransferase	ATGACCGCTGTGGAACAGATTGAGTCCAGATTGCTAGAGCGTGGCATCCCCTTCAACGCAAAAGAACGCCACATGTTCTGTTCTCCTCACATCATTCATCTTGCAGCTTTGGAGCTTTTGAAAGTTATCGGTGCTTTCCCGGAGAAGGGGAAGGAGGATGAGGGAAAGGAATCGGCAGTCTGGCAGGAGGAAGTTACCCGGAAGATCAAGAGGGAAGGTGGAGAACTGCCATTTGAAGACCATTCATAA	MTAVEQIESRLLERGIPFNAKERHMFCSPHIIHLAALELLKVIGAFPEKGKEDEGKESAVWQEEVTRKIKREGGELPFEDHS	MKTRLEQVLERYLNGREVAVWGVPTRRLLRALKPFKFHTADRVDPQYHYVVAVTDDDLTDFLSDEQSKSFQYANDYLTFDDEGGELPFERMCFNVPVGRQTYFGDGVVGACENGYIKSIGQFTSINGTAEIHANHQLNMTFVSDDIQNFFNEESMAVFQEKLRKDPKHPYAYSKEPMTIGSDVYIGAHAFINASTVTSIGDGAIIGSGAVVLENVPPFAVVVGVPARIKRYRFSKEMIETLLRVKWWDWSIEEINENVDALISPELFMKKYGSL	29.93	gnl|BL_ORD_ID|2220|hsp_num:0	2395	True	loose hit with at least 95 percent identity pushed strict
scaffold_800_11 # 9428 # 9550 # -1 # ID=800_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.512	scaffold_800_11 	9428	9550	-	Strict	750	20.0162	tet(52)	100.0	3004587	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGGGCCTTCCAAAGAAGCTGGGAGGGTCCTCATTGGCTTCTGGTATGCTCGAAGGCGTGGGAGGATGTGACGAGACAGGGATCTATAATATGCGAACCCAAAGTGCTGGGAATACATCTTAA	MGLPKKLGGSSLASGMLEGVGGCDETGIYNMRTQSAGNTS	MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH	10.26	gnl|BL_ORD_ID|2756|hsp_num:0	3289	True	loose hit with at least 95 percent identity pushed strict
scaffold_890_5 # 4696 # 4845 # 1 # ID=890_5;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.467	scaffold_890_5 	4696	4845	+	Strict	300	21.1718	lnuA	100.0	3002835	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic inactivation	lincosamide nucleotidyltransferase (LNU)	ATGTTGCGATTGATAATCTTGAAGGAGAATGCACGGCCAGGGTGGAGAACGGAGACTGAGATGGCGAGGGATATGTTGAAGCGTCACTTTGAGGGATTAGGCATACGACTTGCTCTTGTAACCTATTGGCTAGATGGGAAACTCTATTGA	MLRLIILKENARPGWRTETEMARDMLKRHFEGLGIRLALVTYWLDGKLY	MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVIQKLEDIGYKIEVHWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFSETNYKDRKIPCISKEAQLLFHSGYDLTETDHFDIKNLKSIT	30.43	gnl|BL_ORD_ID|22|hsp_num:0	27	True	loose hit with at least 95 percent identity pushed strict
scaffold_1131_3 # 3193 # 3312 # 1 # ID=1131_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.433	scaffold_1131_3 	3193	3312	+	Strict	500	19.631	OXA-299	100.0	3001754	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAGGACTCGGAACGGCGACATAGGTGCTCAGTCGAGAGCCTTGAACTTGAAACATTGTTTTTTATTGGTGCATAAAAGCATTGAAGCAGTCTCACCTGTTTCATCCTCTAAAGACTGA	MRTRNGDIGAQSRALNLKHCFLLVHKSIEAVSPVSSSKD	MNPFTKYCAILCPIIFLGACTISPFSHDQAHSAHASQLTDAATIRNLFNQANVQGVILIKSGNDLQAYGNAIQRADQPFIPASTFKMLNALIGIEHNKTSPDEVFKWNGEKRSFPAWEKDLTLAQAMTASAVPVYQELAHRIGLELMQNEVKRVQFGNGDIGAQVDNFWLMGPLKITPRQEVQFADQLSHLQLPFRKSTQQQVIQMLFIEQIGSKALYAKSGWGMDVEPQVGWYTGWVEDAQGKTTAFSLNLEMDQSTPASLRKELVISSLKQLKIL	14.08	gnl|BL_ORD_ID|2386|hsp_num:0	3461	True	loose hit with at least 95 percent identity pushed strict
scaffold_1136_9 # 6015 # 6122 # 1 # ID=1136_9;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.509	scaffold_1136_9 	6015	6122	+	Strict	700	21.1718	vanSA	100.0	3002931	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGGAGTCGGGCGAAAAGAGAGAACAGGATGCAAAAGGGGAAGGTGCAGATGAAGGAGGAAGGTGTGGCTGGTGGGATGGACGATTGAGTGTTAACATTGTACTGTAG	MESGEKREQDAKGEGADEGGRCGWWDGRLSVNIVL	MVIKLKNKKNDYSKLERKLYMYIVAIVVVAIVFVLYIRSMIRGKLGDWILSILENKYDLNHLDAMKLYQYSIRNNIDIFIYVAIVISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEQKLNTLKRTLEKREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKAYRLEQLIDEFFEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAVIHAPEDLTVSGDPDKLARVFNNILKNAAAYSEDNSIIDITAGLSGDVVSIEFKNTGSIPKDKLAAIFEKFYRLDNARSSDTGGAGLGLAIAKEIIVQHGGQIYAESNDNYTTFRVELPAMPDLVDKRRS	9.11	gnl|BL_ORD_ID|1801|hsp_num:0	1907	True	loose hit with at least 95 percent identity pushed strict
scaffold_1613_5 # 1895 # 2020 # -1 # ID=1613_5;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.421	scaffold_1613_5 	1895	2020	-	Strict	700	20.0162	DHA-12	100.0	3002143	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATTGTCGATGTCTTAAAATTATGTATATACAATTGGAAAGGGATCACGCTGCTGCCAGACGAGTTATCTTCAGTTTTCGACTTTGTCCCATTGGTGGGTACTGTCCCACACGTGGTGCAAATATAG	IVDVLKLCIYNWKGITLLPDELSSVFDFVPLVGTVPHVVQI	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVEAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMSLNDPAAKYRPELTQPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTTRILSPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIVNGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	10.82	gnl|BL_ORD_ID|799|hsp_num:0	846	True	loose hit with at least 95 percent identity pushed strict
scaffold_1657_1 # 1625 # 1864 # -1 # ID=1657_1;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.517	scaffold_1657_1 	1625	1864	-	Strict	1020	22.7126	vgaE	100.0	3002833	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	CAGCGCCGCGTTCGTTCCTCTGCGTTTTCTCGCTTGATCTCTGGACAACAAGCTAGTTCGCTGCCCTCGTCGCACTTTAATCAAGCTGGTGCGGGGCTGGTCTTACAGTCGCAGCGCAGGGACTCTTACTGTTTGGCTGGACGCAAGCTATGGAATCCTTCTATGCGAAGTCCTTTCCCTAGAGATGAAGATACGAGAGCATTGGTTCACTTGGGAGACCCCATCTTATTGCTTTCATGA	QRRVRSSAFSRLISGQQASSLPSSHFNQAGAGLVLQSQRRDSYCLAGRKLWNPSMRSPFPRDEDTRALVHLGDPILLLS	MLLFEGTSLKKHIQDRLLFDIDLIQVHEHQRIGLVGRNGTGKTSLLKIITGEELVDGGNVNHFTSVKLVPQFKETRSEKSGGEITQQYLQLAFNEKPGLLILDEPTTHLDTQRIDWLEKKLANYQGAFVVVSHDRTFLNNVCTEIWEIEDGSLNAFKGDYNAYAEQKELIKTQQQIAFEKYEREKKQLEKAIRQKEERAQRATKKPKNLSSSEARITGAKTHYANIQKKLRGSAKALETRLEQLDRIDKVKELPEIKMDILNKESLTNQSVLRAENIKGEVDGRKLWNPFSLYLYGGDKVAIIGKNGTGKTTLLKKIVERDERIAIPEKVRIGYFSQHLTILDDDKTIIENIQLTSSQDETLIRTVLARMHFWDEDVYKKVGILSGGEKVKVALAKLFLSDVNMLVLDEPTNFLDIESLEALETLMKSYHGTILFVTHDRTLVTNIATKIIDIKDGKITVFDGSYEAYEEWLENQTKSNNDDQLLLIETKISDVLGRLSLEPSRELEDEFQRLLKEKKELTKKL	15.08	gnl|BL_ORD_ID|1532|hsp_num:0	1626	True	loose hit with at least 95 percent identity pushed strict
